GL1X · GenesisL1 explorer

Research workbench

Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor

Analyse Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CWQ
Type
protein
Length
207 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2
Source
HOMO SAPIENS
Molecule
Heat shock protein HSP 90-alpha
UniProt
P07900
Ligands
W2D
Pockets
1 · best druggability 0.67

Structure

x-ray diffraction · resolution 2 · 1 distinct chain · 46% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHeat shock protein HSP 90-alphaprotein20746% helix, 23% strandP07900

Ligands and binding sites

  • W2D · 2-amino-5-(1,3-benzodioxol-5-ylmethyl)[1,2,4]triazolo[1,5-c]quinazoline-8-sulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12950.670.8235W2D

Compared structures

  • 4CWQ · Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.